George Golumbeski - Net Worth and Insider Trading

George Golumbeski Net Worth

The estimated net worth of George Golumbeski is at least $113,056 dollars as of 2024-11-05. George Golumbeski is the Director of Shattuck Labs Inc and owns about 54,613 shares of Shattuck Labs Inc (STTK) stock worth over $65,536. George Golumbeski is the Director of Sage Therapeutics Inc and owns about 8,000 shares of Sage Therapeutics Inc (SAGE) stock worth over $47,520. George Golumbeski is also the Director of Enanta Pharmaceuticals Inc and owns about 0 shares of Enanta Pharmaceuticals Inc (ENTA) stock worth over $0. Details can be seen in George Golumbeski's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that George Golumbeski has not made any transactions after 2022-05-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of George Golumbeski

To

George Golumbeski Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, George Golumbeski owns 5 companies in total, including Shattuck Labs Inc (STTK) , Corbus Pharmaceuticals Holdings Inc (CRBP) , and Sage Therapeutics Inc (SAGE) among others .

Click here to see the complete history of George Golumbeski’s form 4 insider trades.

Insider Ownership Summary of George Golumbeski

Ticker Comapny Transaction Date Type of Owner
STTK Shattuck Labs Inc 2022-04-26 director
CRBP Corbus Pharmaceuticals Holdings Inc 2020-07-06 director
SAGE Sage Therapeutics Inc 2022-05-05 director
LIMIT LIMIT 2019-03-04 director
LIMIT LIMIT 2013-09-18 director

George Golumbeski Latest Holdings Summary

George Golumbeski currently owns a total of 3 stocks. Among these stocks, George Golumbeski owns 54,613 shares of Shattuck Labs Inc (STTK) as of April 26, 2022, with a value of $65,536 and a weighting of 57.97%. George Golumbeski owns 8,000 shares of Sage Therapeutics Inc (SAGE) as of May 5, 2022, with a value of $47,520 and a weighting of 42.03%. George Golumbeski also owns 0 shares of Enanta Pharmaceuticals Inc (ENTA) as of March 4, 2019, with a value of $0 and a weighting of 0%.

Latest Holdings of George Golumbeski

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
STTK Shattuck Labs Inc 2022-04-26 54,613 1.20 65,536
SAGE Sage Therapeutics Inc 2022-05-05 8,000 5.94 47,520
ENTA Enanta Pharmaceuticals Inc 2019-03-04 0 11.26 0

Holding Weightings of George Golumbeski


George Golumbeski Form 4 Trading Tracker

According to the SEC Form 4 filings, George Golumbeski has made a total of 2 transactions in Shattuck Labs Inc (STTK) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Shattuck Labs Inc is the acquisition of 28,330 shares on April 26, 2022, which cost George Golumbeski around $102,838.

According to the SEC Form 4 filings, George Golumbeski has made a total of 1 transactions in Sage Therapeutics Inc (SAGE) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Sage Therapeutics Inc is the acquisition of 8,000 shares on May 5, 2022, which cost George Golumbeski around $251,600.

According to the SEC Form 4 filings, George Golumbeski has made a total of 0 transactions in Enanta Pharmaceuticals Inc (ENTA) over the past 5 years. The most-recent trade in Enanta Pharmaceuticals Inc is the sale of 9,280 shares on March 4, 2019, which brought George Golumbeski around $961,872.

Insider Trading History of George Golumbeski

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

George Golumbeski Trading Performance

GuruFocus tracks the stock performance after each of George Golumbeski's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by George Golumbeski is 21.72%. GuruFocus also compares George Golumbeski's trading performance to market benchmark return within the same time period. The performance of stocks bought by George Golumbeski within 3 months outperforms 3 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how George Golumbeski's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of George Golumbeski

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -10.56 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -6.42 LIMIT LIMIT LIMIT LIMIT LIMIT

George Golumbeski Ownership Network

Ownership Network List of George Golumbeski

No Data

Ownership Network Relation of George Golumbeski

Insider Network Chart

George Golumbeski Owned Company Details

What does Shattuck Labs Inc do?

Who are the key executives at Shattuck Labs Inc?

George Golumbeski is the director of Shattuck Labs Inc. Other key executives at Shattuck Labs Inc include director & Chief Executive Officer Taylor Schreiber , See Remarks Stephen Stout , and See Remarks Andrew R Neill .

Shattuck Labs Inc (STTK) Insider Trades Summary

Over the past 18 months, George Golumbeski made no insider transaction in Shattuck Labs Inc (STTK). Other recent insider transactions involving Shattuck Labs Inc (STTK) include a net purchase of 50,900 shares made by Taylor Schreiber , a net sale of 25,000 shares made by Andrew R Neill , and a net sale of 16,004 shares made by Stephen Stout .

In summary, during the past 3 months, insiders sold 0 shares of Shattuck Labs Inc (STTK) in total and bought 36,500 shares, with a net purchase of 36,500 shares. During the past 18 months, 41,004 shares of Shattuck Labs Inc (STTK) were sold and 59,316 shares were bought by its insiders, resulting in a net purchase of 18,312 shares.

Shattuck Labs Inc (STTK)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Shattuck Labs Inc Insider Transactions

No Available Data

George Golumbeski Mailing Address

Above is the net worth, insider trading, and ownership report for George Golumbeski. You might contact George Golumbeski via mailing address: C/o Celgene Corp., 86 Morris Avenue, Summit Nj 07901.